Specialized Clinical Focus Hassman Research Institute specializes in a wide range of sophisticated clinical trials, including early-phase pharmacology, human abuse liability studies, and psychedelic research, making it an ideal partner for organizations seeking cutting-edge trial capabilities.

Technical Capabilities Equipped with advanced neuroimaging, electrophysiological testing, and drug compounding, HRI offers comprehensive solutions that can attract biotech and pharma companies aiming for innovative, multi-faceted clinical trial approaches.

Growing Industry Presence As part of the Apex Innovative Sciences group with strong industry connections and a recent merger, HRI is positioned to expand its client base among major pharmaceutical players looking for specialized clinical research sites.

Regional Expansion Potential Located in New Jersey with inpatient and outpatient facilities, HRI can serve as a strategic regional partner for companies seeking clinical trial sites in the Northeast U.S. with diverse patient populations.

Financial Stability With revenue estimated between $10 million and $25 million, HRI demonstrates financial viability, making it a reliable partner for long-term clinical trial engagements and collaborative research projects.